stavudine has been researched along with Peripheral Nerve Diseases in 59 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (25.42) | 18.2507 |
| 2000's | 15 (25.42) | 29.6817 |
| 2010's | 26 (44.07) | 24.3611 |
| 2020's | 3 (5.08) | 2.80 |
| Authors | Studies |
|---|---|
| Calixto, JB; da Silva, AM; de Amorim Ferreira, M; de Castro Júnior, CJ; do Prado, CSH; Ferreira, J; Gomez, MV; Junior, SJM; Lückemeyer, DD; Prudente, AS; Tonello, R | 1 |
| Cherry, C; Gaff, J; Kamerman, P; Laws, SM; Pillay, P; Price, P | 1 |
| Cherry, CL; Gaff, J; Imran, D; Laws, SM; Octaviana, F; Price, P; Safri, AY; Setiawan, DD | 1 |
| Bayisa, G; Bokore, A; Korme, B | 1 |
| de Assis Rosa, D; Kamerman, P; Moketla, MB; Wadley, AL | 1 |
| Ariyanto, I; Cherry, C; Gaff, J; Laws, SM; Octaviana, F; Price, P | 1 |
| Lungu, M; Mathews, T; Tapsfield, J; van Oosterhout, JJ | 1 |
| Baiget, M; Cabeza, Mdel C; Domingo, JC; Domingo, P; Fernandez, I; Gutierrez, Mdel M; Martínez, E; Mateo, MG; Ribera, E; Salazar, J; Torres, F; Vidal, F; Villarroya, F | 1 |
| Dandara, C; Kampira, E; Kumwenda, J; van Oosterhout, JJ | 1 |
| Chagoma, N; Heyderman, RS; Kampira, E; Kaunda, S; Mallewa, J; Mukaka, M; Njalale, Y; van Oosterhout, JJ | 1 |
| Chinnery, P; Gardner, K; Heyderman, RS; Kampira, E; Kaunda, S; Mallewa, J; Payne, B; van Oosterhout, JJ | 1 |
| Clifford, DB; Haas, DW; Johnson, DH; Leger, PD; Li, J; McLaren, PJ; Robbins, GK; Shafer, RW | 1 |
| Choudhary, A; Gulati, S; Kabra, SK; Lodha, R; Menon, PR; Sankhyan, N; Sharma, S | 1 |
| Gilks, CF; Kikaire, B; Kiwuwa-Muyingo, S; Levin, JB; Mambule, I; Musana, H; Musoro, G; Walker, AS | 1 |
| Garcia-Perez, E; Serra, J; Solà, R; Sumalla, M | 1 |
| Ananworanich, J; Bennett, K; Chomchey, N; DeGruttola, V; Ebenezer, G; Gerschenson, M; Hauer, P; Hongchookiat, P; Jadwattanakul, T; Mathajittiphun, P; McArthur, JC; Nakamoto, B; Phanuphak, N; Phanuphak, P; Praihirunkit, P; Shikuma, CM; Teeratakulpisarn, N | 1 |
| Birbal, S; Dheda, M; Ojewole, E; Oosthuizen, F | 1 |
| Dionne, RA; Dorsey, SG; Leitch, CC; Lessans, S; Renn, CL; Smith, BA; Wang, XM | 1 |
| Affandi, JS; Cherry, CL; Imran, D; Kamarulzaman, A; Price, P; Smyth, K; Vanar, S; Yunihastuti, E | 1 |
| Boulle, A; Meintjes, G; Osler, M; Rebe, K; Stead, D | 1 |
| Atté, EF; Mugabo, J; Rasschaert, F; Reid, T; van Griensven, J; Zachariah, R | 1 |
| Badri, M; Benatar, M; Dave, JA; Harrison, TB; Heckmann, JM; Levitt, NS; Maritz, J | 1 |
| Affandi, JS; Brew, BJ; Cherry, CL; Creighton, J; Djauzi, S; Hooker, DJ; Imran, D; Kamarulzaman, A; Kamerman, P; McArthur, JC; Moore, RD; Price, P; Smyth, K; Tan, IL; Vanar, S; Wadley, A; Wesselingh, SL; Yunihastuti, E | 1 |
| Aghafar, Z; Cherry, CL; Chew, CS; Gut, I; Imran, D; Ismail, R; Kamarulzaman, A; Phipps, M; Price, P; Varna, S; Yunihastuti, E | 1 |
| Cherry, CL; Kamerman, PR; Price, P; Wadley, AL | 1 |
| Dorsey, SG; Leitch, CC; Lessans, S; McGuire, WC; Renn, CL; Rhee, P; Smith, BA; Traub, RJ | 1 |
| Anwikar, SR; Bandekar, MS; Kshirsagar, NA; Pazare, AP; Smrati, B; Tatke, PA | 1 |
| Glesby, MJ; Grobler, A; Gumede, S; Karim, F; Naidoo, K; Pahuja, M; Parker, G | 1 |
| Benki-Nugent, SF; Chung, MH; Etyang, A; John-Stewart, GC; Kohler, PK; McGrath, CJ; Njoroge, J; Thiga, JW | 1 |
| Ananworanich, J; Chomchey, N; Degruttola, V; Ebenezer, G; Gerschenson, M; Hauer, P; Hongchookiath, P; Jadwattanakul, T; Liang, CY; Mathajittiphun, P; McArthur, J; Nakamoto, B; Phanuphak, N; Phanuphak, P; Praihirunkit, P; Shikuma, C; Teeratakulpisarn, N; Valcour, V | 1 |
| Ananworanich, J; Chomchey, N; Gerschenson, M; Hongchookiat, P; Jadwattanakul, T; Kerr, SJ; Kim, JH; Mathajittiphun, P; Phanuphak, N; Phanuphak, P; Pinyakorn, S; Praihirunyakit, P; Rungrojrat, P; Shikuma, C; Teeratakulpisarn, N; Valcour, V | 1 |
| Bunting, S; Manji, H; Miller, RF; Sadiq, ST | 1 |
| Moyle, G | 1 |
| Brew, BJ; Law, M; Tisch, S | 1 |
| Asiimwe, F; Behumbiize, P; Brooks, JT; Forna, F; Liechty, CA; Mermin, J; Solberg, P; Tong, T; Weidle, PJ; Were, W | 1 |
| de Ruiter, A; Lechelt, M; McCormick, S | 1 |
| Bourgeois, A; Calmy, A; Ciaffi, L; Delaporte, E; Kouanfack, C; Koulla-Shiro, S; Laurent, C; Mougnutou, R; Mpoudi-Ngolé, E; Nkoué, N | 1 |
| Balakrishnan, P; Cecelia, AJ; Devaleenal, B; Flanigan, TP; Kumarasamy, N; Lai, AR; Mayer, KH; Poongulali, S; Saghayam, S; Solomon, S; Venkatesh, KK; Yepthomi, T | 1 |
| Delaporte, E; Kouanfack, C; Laurent, C; Makinson, A; Moing, VL | 1 |
| Simpson, DM; Tagliati, M | 1 |
| Skowron, G | 1 |
| Adler, M; Anderson, RE; Cross, A; Dunkle, LM; Kriesel, D; Martin, RR; Smaldone, L; Wirtz, C | 1 |
| Anderson, RE; Cross, A; Dunkle, LM; Hassett, J; Murray, HW; Sacks, HS; Sledz, S; Squires, KE; Weiss, W | 1 |
| Anderson, RE; Cross, A; Dunkle, LM; Follansbee, S; Hardy, WD; Petersen, EA; Peterson, DM; Ramírez-Ronda, CH; Sacks, HS; Schwartz, R | 1 |
| Browne, MJ; Chafee, SB; Denman, SL; Dudley, MN; Geletko, SM; Graham, KK; Mayer, KH; Posner, MR; Steinberg, SM; Zinner, SH | 1 |
| De Simone, C; Famularo, G; Longo, A; Marcellini, S; Moretti, S; Santini, G; Trinchieri, V; Tzantzoglou, S | 1 |
| Dudley, MN; Rana, KZ | 1 |
| Moyle, GJ; Sadler, M | 1 |
| Beall, G; Cross, AP; Dunkle, LM; Gathe, J; Hardy, D; Murphy, RL; Peterson, D; Pollard, RB; Pottage, J; Reynolds, L; Rutkievicz, V | 1 |
| Denisi, R; Izopet, J; Massip, P; Pellegrin, I; Reynes, J; Segondy, M | 1 |
| Keruly, JC; McArthur, JC; Moore, RD; Wong, WM | 1 |
| Cepeda, JA; Wilks, D | 1 |
| Breen, RA; Johnson, MA; Lipman, MC | 1 |
| Bernasconi, E; Bucher, HC; Fagard, C; Hirschel, B; Ledergerber, B; Leduc, D; Malinverni, R; Opravil, M; Perrin, L; Rutschmann, OT; Telenti, A; Vernazza, PL | 1 |
| Conant, M | 1 |
| Friedland, GH; Gulick, RM | 1 |
| del Rio, C; Little, S | 1 |
| Chennebault, JM; Lafeuillade, A; Mussini, JM; Raffi, F; Reliquet, V | 1 |
| Keilbaugh, SA; Prusoff, WH; Simpson, MV | 1 |
6 review(s) available for stavudine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Double "d" drug danger.
Topics: Acidosis, Lactic; Anti-HIV Agents; Didanosine; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV-Associated Lipodystrophy Syndrome; Humans; Peripheral Nervous System Diseases; Practice Guidelines as Topic; Stavudine | 2003 |
Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings.
Topics: Acidosis, Lactic; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Health Resources; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Sex Factors; Stavudine | 2008 |
Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.
Topics: Animals; Didanosine; Dideoxynucleosides; Disease Models, Animal; HIV Infections; Humans; Peripheral Nervous System Diseases; Stavudine; Zalcitabine | 1995 |
Biologic effects and safety of stavudine: overview of phase I and II clinical trials.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Body Weight; CD4 Lymphocyte Count; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; HIV Core Protein p24; HIV Infections; Humans; Peripheral Nervous System Diseases; Stavudine | 1995 |
Clinical pharmacokinetics of stavudine.
Topics: Adult; Anti-HIV Agents; Child; HIV Infections; Humans; Infant; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Stavudine | 1997 |
Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management.
Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Stavudine; Zalcitabine; Zidovudine | 1998 |
13 trial(s) available for stavudine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.
Topics: Adolescent; Adult; Aged; Anti-Retroviral Agents; Antitubercular Agents; Didanosine; Female; HIV Infections; Humans; Incidence; Isoniazid; Male; Middle Aged; Peripheral Nervous System Diseases; Prevalence; Risk Factors; Stavudine; Uganda; Young Adult; Zidovudine; Zimbabwe | 2014 |
Distal leg epidermal nerve fiber density as a surrogate marker of HIV-associated sensory neuropathy risk: risk factors and change following initial antiretroviral therapy.
Topics: Adult; Anti-Retroviral Agents; Cross-Sectional Studies; Female; HIV Infections; Humans; Leg; Male; Peripheral Nervous System Diseases; Risk Factors; Sensory Receptor Cells; Skin; Stavudine; Tenofovir; Thailand; Zidovudine | 2015 |
A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapine.
Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Diet; Drug Administration Schedule; Drug Substitution; Female; Glomerular Filtration Rate; Hemoglobins; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Organophosphonates; Peripheral Nervous System Diseases; Stavudine; Tenofovir; Treatment Outcome; Viral Load; Zidovudine | 2012 |
Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
Topics: Adult; Anemia; Anti-HIV Agents; Cameroon; CD4 Lymphocyte Count; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Multivariate Analysis; Nevirapine; Patient Compliance; Peripheral Nervous System Diseases; Prospective Studies; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2008 |
Biologic effects and safety of stavudine: overview of phase I and II clinical trials.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Body Weight; CD4 Lymphocyte Count; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; HIV Core Protein p24; HIV Infections; Humans; Peripheral Nervous System Diseases; Stavudine | 1995 |
Design and implementation of the stavudine parallel-track program.
Topics: Adult; Body Weight; Double-Blind Method; Female; HIV Infections; Humans; Male; Peripheral Nervous System Diseases; Regression Analysis; Stavudine; Survival Rate | 1995 |
Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Body Weight; CD4 Lymphocyte Count; Female; HIV Core Protein p24; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Proportional Hazards Models; Stavudine; Survival Analysis | 1995 |
Dose-related activity of stavudine in patients infected with human immunodeficiency virus.
Topics: Adult; Aged; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; HIV; HIV Core Protein p24; HIV Infections; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Stavudine; Survival Analysis; Weight Gain | 1995 |
2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Antiviral Agents; CD4-Positive T-Lymphocytes; Dideoxynucleosides; Female; HIV Core Protein p24; Humans; Leukocyte Count; Male; Middle Aged; Peripheral Nervous System Diseases; Stavudine | 1993 |
Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues.
Topics: Acetylcarnitine; Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Axons; Cross-Sectional Studies; Didanosine; Female; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Stavudine; Zalcitabine | 1997 |
Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3.
Topics: Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; RNA, Viral; Stavudine; Viral Load; Virus Replication; Weight Gain | 1999 |
Once-daily administration of didanosine in combination with stavudine in antiretroviral-naive patients. The STADI Group.
Topics: Anti-HIV Agents; Didanosine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Patient Compliance; Peripheral Nervous System Diseases; RNA, Viral; Stavudine | 1999 |
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study.
Topics: Anti-HIV Agents; Diarrhea; Didanosine; Drug Therapy, Combination; Enzyme Inhibitors; Follow-Up Studies; HIV Infections; HIV-1; Humans; Hydroxyurea; Nausea; Peripheral Nervous System Diseases; Stavudine | 2000 |
41 other study(ies) available for stavudine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Critical Pronociceptive Role of Family 2 Voltage-Gated Calcium Channels in a Novel Mouse Model of HIV-Associated Sensory Neuropathy.
Topics: Animals; Calcium Channels, N-Type; Chronic Pain; Female; HIV Infections; Male; Mice; Mice, Inbred C57BL; Peripheral Nervous System Diseases; Stavudine | 2023 |
The role of CAMKK2 polymorphisms in HIV-associated sensory neuropathy in South Africans.
Topics: Calcium-Calmodulin-Dependent Protein Kinase Kinase; HIV Infections; Humans; Peripheral Nervous System Diseases; Polymorphism, Single Nucleotide; Quality of Life; Stavudine | 2020 |
Brief Report: Demographic and Genetic Associations With Markers of Small and Large Fiber Sensory Neuropathy in HIV Patients Treated Without Stavudine.
Topics: Adult; Alleles; Anti-HIV Agents; Biomarkers; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Female; Genetic Predisposition to Disease; HIV Infections; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Risk Factors; Stavudine; Young Adult | 2020 |
Determinants of anti-retroviral regimen changes among HIV/AIDS patients of east and west Wollega zone health institutions, Oromia region, west Ethiopia: a cross-sectional study.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Chemical and Drug Induced Liver Injury; Cross-Sectional Studies; Drug Substitution; Ethiopia; HIV Infections; Humans; Lamivudine; Nevirapine; Peripheral Nervous System Diseases; Retrospective Studies; Stavudine | 2018 |
Pharmacogenetic variation influences sensory neuropathy occurrence in Southern Africans treated with stavudine-containing antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Black People; Case-Control Studies; Cell Cycle Proteins; Female; HIV Infections; Humans; Male; Membrane Transport Proteins; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Peripheral Nervous System Diseases; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Ribonucleotide Reductases; SAM Domain and HD Domain-Containing Protein 1; South Africa; Stavudine | 2018 |
Polymorphisms in CAMKK2 associate with susceptibility to sensory neuropathy in HIV patients treated without stavudine.
Topics: Adult; Anti-HIV Agents; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Female; Genetic Predisposition to Disease; HIV Infections; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Polymorphism, Single Nucleotide; Prevalence; Stavudine | 2019 |
Underreporting of side effects of standard first-line ART in the routine setting in Blantyre, Malawi.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Ambulatory Care Facilities; Anti-HIV Agents; Cross-Sectional Studies; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Interviews as Topic; Lamivudine; Lipodystrophy; Malawi; Male; Middle Aged; Nevirapine; Peripheral Nervous System Diseases; Prevalence; Stavudine; Surveys and Questionnaires; Urban Population | 2011 |
Association of thymidylate synthase polymorphisms with acute pancreatitis and/or peripheral neuropathy in HIV-infected patients on stavudine-based therapy.
Topics: Acute Disease; HIV Infections; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Pancreatitis; Peripheral Nervous System Diseases; Polymorphism, Genetic; Reverse Transcriptase Inhibitors; Stavudine; Thymidylate Synthase | 2013 |
Mitochondrial DNA subhaplogroups L0a2 and L2a modify susceptibility to peripheral neuropathy in malawian adults on stavudine containing highly active antiretroviral therapy.
Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Creatinine; Cross-Sectional Studies; Disease Susceptibility; DNA, Mitochondrial; Female; Genetic Variation; Haplotypes; HIV Infections; Humans; Malawi; Male; Middle Aged; Peripheral Nervous System Diseases; Stavudine; Viral Load | 2013 |
Longitudinal lactate levels from routine point-of-care monitoring in adult Malawian antiretroviral therapy patients: associations with stavudine toxicities.
Topics: Acidosis, Lactic; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Drug Costs; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lactic Acid; Lipodystrophy; Malawi; Male; Medically Underserved Area; Peripheral Nervous System Diseases; Point-of-Care Systems; Prospective Studies; Stavudine | 2013 |
Severe toxicity and polymerase-γ gene abnormalities in Malawian adults on stavudine-based antiretroviral therapy.
Topics: Acidosis, Lactic; Adult; Anti-HIV Agents; Cohort Studies; DNA Polymerase gamma; DNA-Directed DNA Polymerase; DNA, Mitochondrial; Female; Genetic Variation; HIV Infections; Humans; Malawi; Male; Middle Aged; Peripheral Nervous System Diseases; Polymorphism, Single Nucleotide; Stavudine | 2013 |
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Case-Control Studies; Drug Combinations; Drug Therapy, Combination; Genome-Wide Association Study; Genotype; Humans; Lamivudine; Multicenter Studies as Topic; Peripheral Nervous System Diseases; Polymorphism, Genetic; Principal Component Analysis; Randomized Controlled Trials as Topic; Retrospective Studies; Stavudine; Treatment Outcome; Zidovudine | 2014 |
Peripheral neuropathy in children on stauvudine therapy.
Topics: Adolescent; Anti-HIV Agents; Child; Cross-Sectional Studies; Female; HIV Infections; Humans; Male; Neural Conduction; Neurologic Examination; Outcome Assessment, Health Care; Outpatients; Peripheral Nervous System Diseases; Stavudine | 2015 |
Behavioral and electrophysiological abnormalities in two rat models of antiretroviral drug-induced neuropathy.
Topics: Action Potentials; Animals; Anti-HIV Agents; Disease Models, Animal; Male; Nerve Fibers, Unmyelinated; Neural Conduction; Neurophysiology; Pain Measurement; Pain Threshold; Peripheral Nervous System Diseases; Physical Stimulation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Stavudine; Zalcitabine | 2015 |
Adverse drug reactions associated with antiretroviral therapy in South Africa.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dizziness; Exanthema; Female; Gynecomastia; HIV Infections; Humans; Lipodystrophy; Male; Middle Aged; Nevirapine; Peripheral Nervous System Diseases; Renal Insufficiency; Retrospective Studies; South Africa; Stavudine; Tenofovir; Zidovudine | 2016 |
Genome-wide screen identifies drug-induced regulation of the gene giant axonal neuropathy (Gan) in a mouse model of antiretroviral-induced painful peripheral neuropathy.
Topics: Analysis of Variance; Animals; Blotting, Western; Chromosome Mapping; Cytoskeletal Proteins; Disease Models, Animal; Down-Regulation; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Nursing Research; Oligonucleotide Array Sequence Analysis; Peripheral Nervous System Diseases; Polymerase Chain Reaction; Protein Array Analysis; Reverse Transcriptase Inhibitors; Stavudine; Time Factors | 2009 |
Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
Topics: Adolescent; Adult; Age Factors; Aged; Aging; Anthropometry; Anti-HIV Agents; Body Height; Causality; Developing Countries; Female; HIV Infections; Humans; Male; Mass Screening; Middle Aged; Peripheral Nervous System Diseases; Predictive Value of Tests; Prescriptions; Risk Assessment; Risk Factors; Stavudine; Young Adult | 2009 |
Risk factors for and clinical characteristics of severe hyperlactataemia in patients receiving antiretroviral therapy: a case-control study.
Topics: Acidosis, Lactic; Adult; Alanine Transaminase; Anti-HIV Agents; Developing Countries; Drug Administration Schedule; Epidemiologic Methods; Female; Humans; Lactic Acid; Male; Overweight; Peripheral Nervous System Diseases; Pregnancy; Reverse Transcriptase Inhibitors; South Africa; Stavudine; Weight Loss | 2010 |
Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda.
Topics: Acidosis, Lactic; Adult; Age Factors; Anti-HIV Agents; Drug Therapy, Combination; Drugs, Generic; Exanthema; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Longitudinal Studies; Male; Nevirapine; Peripheral Nervous System Diseases; Proportional Hazards Models; Risk Factors; Rwanda; Stavudine; Time Factors | 2010 |
HIV neuropathy in South Africans: frequency, characteristics, and risk factors.
Topics: Adult; Age Distribution; Age Factors; Alcoholism; Anti-HIV Agents; Causality; CD4 Lymphocyte Count; Cross-Sectional Studies; Female; HIV Infections; Humans; Male; Paresthesia; Peripheral Nervous System Diseases; Prospective Studies; Retrospective Studies; Risk Assessment; Risk Factors; South Africa; Stavudine; Surveys and Questionnaires; Tuberculosis | 2010 |
Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV.
Topics: Adult; Age Factors; Aged; Body Height; Cohort Studies; Comorbidity; Cross-Sectional Studies; Female; Hepatitis C; HIV Infections; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Risk Factors; Seroepidemiologic Studies; Stavudine; Young Adult | 2010 |
Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and Caucasian human immunodeficiency virus patients.
Topics: Anthropometry; Anti-HIV Agents; Asian People; Body Height; Genotype; Haplotypes; HIV; HIV Infections; Humans; Peripheral Nervous System Diseases; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Assessment; Risk Factors; Stavudine; Tumor Necrosis Factors; White People | 2011 |
HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans.
Topics: Adult; Age Factors; Anti-HIV Agents; Body Height; Female; HIV Infections; Humans; Logistic Models; Male; Pain; Peripheral Nervous System Diseases; Risk Factors; South Africa; Stavudine | 2011 |
Brain-derived neurotrophic factor modulates antiretroviral-induced mechanical allodynia in the mouse.
Topics: Animals; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Hyperalgesia; Injections, Spinal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peripheral Nervous System Diseases; Posterior Horn Cells; Receptor, trkB; Recombinant Fusion Proteins; Reverse Transcriptase Inhibitors; Stavudine | 2011 |
HAART induced adverse drug reactions: a retrospective analysis at a tertiary referral health care center in India.
Topics: Alkynes; Anemia; Antiretroviral Therapy, Highly Active; Benzoxazines; Chemical and Drug Induced Liver Injury; Cyclopropanes; Exanthema; Female; Gastritis; HIV Infections; Humans; India; Lamivudine; Male; Nevirapine; Peripheral Nervous System Diseases; Pharmacovigilance; Retrospective Studies; Severity of Illness Index; Sjogren's Syndrome; Stavudine | 2011 |
Effects of a reduced dose of stavudine on the incidence and severity of peripheral neuropathy in HIV-infected adults in South Africa.
Topics: Adult; Anti-HIV Agents; Dose-Response Relationship, Drug; Female; HIV Infections; Humans; Incidence; Male; Peripheral Nervous System Diseases; Practice Guidelines as Topic; Retrospective Studies; South Africa; Stavudine; Young Adult | 2012 |
Increased incidence of symptomatic peripheral neuropathy among adults receiving stavudine- versus zidovudine-based antiretroviral regimens in Kenya.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Incidence; Kenya; Male; Peripheral Nervous System Diseases; Probability; Retrospective Studies; Stavudine; Treatment Outcome; Zidovudine | 2012 |
Determinants of epidermal nerve fibre density in antiretroviral-naïve HIV-infected individuals.
Topics: Adult; Age Distribution; Anti-HIV Agents; Body Mass Index; Female; HIV Seropositivity; Humans; Male; Nerve Fibers; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Polyneuropathies; Predictive Value of Tests; Stavudine; Thailand | 2012 |
Peripheral neuropathy in patients with HIV infection: consider dual pathology.
Topics: Adult; Anti-HIV Agents; Charcot-Marie-Tooth Disease; Diagnosis, Differential; Female; HIV Infections; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Stavudine | 2002 |
Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Humans; Lactates; Peripheral Nervous System Diseases; Sensitivity and Specificity; Stavudine; Viral Load | 2003 |
Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Cyclopropanes; Exanthema; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Nevirapine; Pancreatitis; Peripheral Nervous System Diseases; Proportional Hazards Models; Rural Health; Stavudine; Survival Analysis; Uganda | 2007 |
Usage of stavudine (D4T) - a retrospective analysis in a South London hospital.
Topics: Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Hyperlipidemias; Lipodystrophy; London; Male; Middle Aged; Peripheral Nervous System Diseases; Practice Guidelines as Topic; Retrospective Studies; Stavudine | 2007 |
Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients.
Topics: Adult; Anemia; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Drugs, Generic; Exanthema; Female; HIV Infections; Humans; Incidence; India; Male; Nevirapine; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Stavudine | 2008 |
Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea.
Topics: Adult; Aged; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Female; HIV Infections; Humans; Hydroxyurea; Incidence; Male; Middle Aged; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Stavudine | 2000 |
Excess peripheral neuropathy in patients treated with hydroxyurea plus didanosine and stavudine for HIV infection.
Topics: Anti-HIV Agents; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Hydroxyurea; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Stavudine | 2000 |
Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals.
Topics: Adult; Aged; Anti-HIV Agents; Antitubercular Agents; Drug Therapy, Combination; HIV Infections; Humans; Isoniazid; Middle Aged; Peripheral Nervous System Diseases; Stavudine | 2000 |
New antiretroviral strategies: interview with Marcus Conant, M.D. Interview by John S. James.
Topics: Antiviral Agents; CD4 Lymphocyte Count; DNA, Viral; Drug Therapy, Combination; HIV; HIV Infections; Humans; Isoquinolines; Lamivudine; Peripheral Nervous System Diseases; Protease Inhibitors; Quinolines; Saquinavir; Stavudine; Zalcitabine; Zidovudine | 1995 |
Too little of a good thing.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Nelfinavir; Patient Compliance; Peripheral Nervous System Diseases; Reverse Transcriptase Inhibitors; Stavudine; Viral Load | 1998 |
Time for a change?
Topics: Adult; Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; Humans; Male; Peripheral Nervous System Diseases; Stavudine | 1998 |
Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Electromyography; Female; HIV Infections; Humans; Incidence; Male; Peripheral Nervous System Diseases; Pilot Projects; Reverse Transcriptase Inhibitors; Risk Factors; Safety; Stavudine; Treatment Outcome | 2001 |
The PC12 cell as a model for studies of the mechanism of induction of peripheral neuropathy by anti-HIV-1 dideoxynucleoside analogs.
Topics: Animals; Axons; Bone Marrow; Cell Division; Cell Line, Transformed; Didanosine; Dideoxynucleosides; Dose-Response Relationship, Drug; Peripheral Nervous System Diseases; Stavudine; Tumor Cells, Cultured; Zalcitabine; Zidovudine | 1991 |